3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Neoplasms
15
Papillomavirus Infections
9
Uterine Cervical Neoplasms
7
Pancreatic Neoplasms
6
Ovarian Neoplasms
5
Breast Neoplasms
5
Prostatic Neoplasms
4
Neuroendocrine Tumors
3
Neoplasm Metastasis
3
Myasthenia Gravis
3
Multiple Myeloma
3
Melanoma
3
Lymphoma
3
Lung Neoplasms
3
Autoimmune Diseases
3
Thyroid Diseases
2
Pancreatic Cyst
2
Neuroblastoma
2
Mesothelioma, Malignant
2
Lymphoma, Non-Hodgkin
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
COVID-19
2
Brain Neoplasms
2
Abortion, Spontaneous
2
Interventions
Quality of Life
2
Drug Therapy
2
Blood Specimen Collection
2
Tumor Burden
1
Syndecan-1
1
Patient Reported Outcome Measures
1
Oxaliplatin
1
Osteopontin
1
Observation
1
Molecular Diagnostic Techniques
1
Mitoxantrone
1
Mesothelin
1
Leucovorin
1
Immunotherapy
1
Ifosfamide
1
Hyaluronic Acid
1
Histocompatibility Testing
1
Fluorouracil
1
Doxorubicin
1
Data Collection
1
Comparative Genomic Hybridization
1
Cisplatin
1
Blood Component Removal
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Mesothelioma
×
Data Collection
×
Clear all
NCT05308966
2025-10-06
MESO-IMMUNE
Groupe Francais De Pneumo-Cancerologie
Completed
204 enrolled